MIR4776-1: A Drug Target / Disease Biomarker (G100616267)
MIR4776-1: A Drug Target / Disease Biomarker
MIR4776-1 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the mir gene family, which encodes a family of cytoskeleton-associated proteins.
One of the unique features of MIR4776-1 is its ability to interact with various signaling molecules, including TGF-β1, NF-kappa-B, and Hedgehog. This suggests that MIR4776-1 may play a role in cell signaling and development.
MIR4776-1 has also been shown to be involved in the regulation of inflammation and immune responses. It has been shown to interact with various immune cells, including T cells and macrophages, and to contribute to the regulation of inflammation-related processes.
In addition to its potential role in cell signaling and development, MIR4776-1 has also been shown to be involved in the regulation of body weight and metabolism. It has been shown to interact with various genes that are involved in metabolism, including the leptin receptor, which is responsible for regulating food intake and body weight.
MIR4776-1 is also of interest because it is expressed in a variety of tissues and organs, including the brain, which suggests that it may be involved in the regulation of brain function. This is an important area, as the brain is involved in many important cognitive and behavioral processes.
In conclusion, MIR4776-1 is a protein that has been shown to interact with various signaling molecules and to contribute to the regulation of cell signaling, development, inflammation, and body weight. These properties make it an attractive target for research and potential therapeutic intervention. Further studies are needed to fully understand the role of MIR4776-1 in these processes and to determine its potential as a drug or biomarker.
Protein Name: MicroRNA 4776-1
The "MIR4776-1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4776-1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
MIR4776-2 | MIR4777 | MIR4778 | MIR4779 | MIR4780 | MIR4781 | MIR4782 | MIR4783 | MIR4784 | MIR4785 | MIR4786 | MIR4787 | MIR4789 | MIR4790 | MIR4791 | MIR4793 | MIR4794 | MIR4795 | MIR4796 | MIR4797 | MIR4798 | MIR4799 | MIR4800 | MIR4802 | MIR4803 | MIR4804 | MIR483 | MIR484 | MIR485 | MIR486-1 | MIR486-2 | MIR487A | MIR487B | MIR488 | MIR489 | MIR490 | MIR491 | MIR492 | MIR493 | MIR494 | MIR495 | MIR496 | MIR497 | MIR497HG | MIR498 | MIR4999 | MIR499A | MIR499B | MIR5000 | MIR5001 | MIR5002 | MIR5003 | MIR5004 | MIR5006 | MIR5007 | MIR5008 | MIR5009 | MIR500A | MIR500B | MIR501 | MIR5010 | MIR5011 | MIR502 | MIR503 | MIR503HG | MIR504 | MIR5047 | MIR505 | MIR506 | MIR507 | MIR508 | MIR5088 | MIR5089 | MIR509-1 | MIR509-2 | MIR509-3 | MIR5090 | MIR5091 | MIR5092 | MIR5093 | MIR5094 | MIR510 | MIR5100 | MIR511 | MIR511-2 | MIR512-1 | MIR512-2 | MIR513A1 | MIR513A2 | MIR513B | MIR513C | MIR514A1 | MIR514A2 | MIR514A3 | MIR514B | MIR515-1 | MIR515-2 | MIR516A1 | MIR516A2 | MIR516B1
